Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-01-24 @ 5:20 PM
Study NCT ID:
NCT00305734
Status:
COMPLETED
Last Update Posted:
2013-01-25
First Post:
2006-03-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer
Sponsor:
National Cancer Institute (NCI)
Organization: